Advanced search

Camelid single-domain antibodies as a therapeutic approach for familial amyloidosis of the Finnish type (FAF)

Author
Organization

Citation

Please use this url to cite or link to this publication:

Chicago
Van Overbeke, Wouter, M Guaraldo, Joël Vandekerckhove, Ariane De Ganck, and Jan Gettemans. 2010. “Camelid Single-domain Antibodies as a Therapeutic Approach for Familial Amyloidosis of the Finnish Type (FAF).” In Amyloid-journal of Protein Folding Disorders, 17:97–97.
APA
Van Overbeke, W., Guaraldo, M., Vandekerckhove, J., De Ganck, A., & Gettemans, J. (2010). Camelid single-domain antibodies as a therapeutic approach for familial amyloidosis of the Finnish type (FAF). AMYLOID-JOURNAL OF PROTEIN FOLDING DISORDERS (Vol. 17, pp. 97–97). Presented at the 12th International symposium on Amyloidosis from Molecular Mechanisms toward the Cure of Systemic Amyloidoses.
Vancouver
1.
Van Overbeke W, Guaraldo M, Vandekerckhove J, De Ganck A, Gettemans J. Camelid single-domain antibodies as a therapeutic approach for familial amyloidosis of the Finnish type (FAF). AMYLOID-JOURNAL OF PROTEIN FOLDING DISORDERS. 2010. p. 97–97.
MLA
Van Overbeke, Wouter, M Guaraldo, Joël Vandekerckhove, et al. “Camelid Single-domain Antibodies as a Therapeutic Approach for Familial Amyloidosis of the Finnish Type (FAF).” Amyloid-journal of Protein Folding Disorders. Vol. 17. 2010. 97–97. Print.
@inproceedings{1061097,
  author       = {Van Overbeke, Wouter and Guaraldo, M and Vandekerckhove, Joël and De Ganck, Ariane and Gettemans, Jan},
  booktitle    = {AMYLOID-JOURNAL OF PROTEIN FOLDING DISORDERS},
  issn         = {1350-6129},
  language     = {eng},
  location     = {Rome, Italy},
  number       = {suppl. 1},
  pages        = {97--97},
  title        = {Camelid single-domain antibodies as a therapeutic approach for familial amyloidosis of the Finnish type (FAF)},
  volume       = {17},
  year         = {2010},
}

Web of Science
Times cited: